NCT07238075 2026-02-17
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Adcytherix SAS
Phase 1 Recruiting
Adcytherix SAS
Second Affiliated Hospital, School of Medicine, Zhejiang University
Shanghai Juncell Therapeutics
Guangzhou FineImmune Biotechnology Co., LTD.